Revenue: The sum of all revenue fields included for a company's operating activities.
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Revenue of $2.79B for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$2.79B |
$-116.89M |
|
$1.77B |
|
$1.02B |
|
$2.54B |
|
$249.33M |
|
$-304.34M |
|
$-55.01M |
|
$-55.01M |
|
$-73.88M |
|
$-73.88M |
|
$-73.88M |
|
$-73.88M |
|
$249.33M |
|
$514.61M |
|
308.98M |
|
308.98M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$1.59B |
|
$424.91M |
|
$1.91B |
|
$3.50B |
|
$1.13B |
|
$2.16B |
|
$2.48B |
|
$3.61B |
|
$-109.51M |
|
$-1.44B |
|
$-109.51M |
|
309.88M |
|
| Cash Flow Statement Financials | |
$295.10M |
|
$-63.00M |
|
$-211.79M |
|
$99.11M |
|
$118.42M |
|
$19.31M |
|
$27.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.41 |
|
-- |
|
-- |
|
1.05 |
|
-22.70 |
|
36.52% |
|
8.92% |
|
8.92% |
|
18.42% |
|
-1.97% |
|
-4.18% |
|
$234.76M |
|
-- |
|
-- |
|
-- |
|
0.80 |
|
2.90 |
|
3.60 |
|
101.40 |
|
67.46% |
|
5.13% |
|
-2.11% |
|
-3.60% |
|
$-0.35 |
|
$0.76 |
|
$0.96 |
|